Lorlatinib - PF-06463922
NCT03127618
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Interventions
DRUG:
Lorlatinib
Sponsor
Pfizer